Skip to Main Content

Paper Details

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts.
BMJ
126
2018
PARTICIPANTS, PCa, PSA, SNPs, aggressive cancer, cancer, custom (iCOGS) array, men, participants, prostate cancer, prostate specific antigen, single nucleotide polymorphisms
Author NameAffiliation
Chun Chieh FanCenter for Multimodal Imaging and Genetics, University of California
Chun Chieh FanUniversity of California
Yunpeng WangOslo University Hospital and University of Oslo
John K ParsonsUniversity of California
Rosalind A EelesInstitute of Cancer Research
Rosalind A EelesRoyal Marsden NHS Foundation Trust
Douglas F EastonUniversity of Cambridge
Zsofia Kote-JaraiInstitute of Cancer Research
Henrik Gr??nbergKarolinska Institutet
Henrik Gr??nbergKarolinska Institutet
Fredrik WiklundKarolinska Institutet
Johanna SchleutkerInstitute of Biomedicine, FI-20014 University of Turku
Johanna Schleutker30014 University of Tampere
Johanna SchleutkerTurku University Hospital
Johanna SchleutkerInstitute of Biomedicine, FI-20014 University of Turku
Johanna SchleutkerTurku University Hospital
Johanna Schleutker30014 University of Tampere
Børge G NordestgaardUniversity of Copenhagen
Børge G NordestgaardHerlev and Gentofte Hospital, Copenhagen University Hospital
Sune F NielsenUniversity of Copenhagen
Sune F NielsenHerlev and Gentofte Hospital, Copenhagen University Hospital
Timothy J KeyNuffield Department of Population Health University of Oxford
Ruth C TravisNuffield Department of Population Health University of Oxford
David E NealUniversity of Oxford, John Radcliffe Hospital
David E NealUniversity of Cambridge, Addenbrooke's Hospital
Freddie C HamdyUniversity of Oxford, John Radcliffe Hospital
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Kay-Tee KhawClinical Gerontology Unit, University of Cambridge
Cezary CybulskiInternational Hereditary Cancer Centre, Pomeranian Medical University
Judith A ClementsAustralian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Science, Queensland University of Technology
Amanda B SpurdleQueensland Institute of Medical Research
Amanda B SpurdleQueensland Institute of Medical Research
Amanda B SpurdleInstitute of Health and Biomedical Innovation and School of Biomedical Science, Queensland University of Technology
Amanda B SpurdleAustralian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Science, Queensland University of Technology
Amanda B SpurdleAustralian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Science, Queensland University of Technology
Amanda B SpurdleInstitute of Health and Biomedical Innovation and School of Biomedical Science, Queensland University of Technology
David S KarowCenter for Multimodal Imaging and Genetics, University of California
David S KarowUniversity of California
Ian G MillsOslo University Hospital and University of Oslo
Ian G MillsQueens University Belfast
Ian G MillsUniversity of Oxford, John Radcliffe Hospital
Ole A AndreassenOslo University Hospital and University of Oslo
Anders M DaleCenter for Multimodal Imaging and Genetics, University of California
Anders M DaleUniversity of California
Anders M DaleUniversity of California
  • 1 - 46

Datasets